NeuroEndocrine tumor therapy with lutetium-177-octreotate and everolimus (NETTLE): A Phase I study

P.G. Claringbold, J Turner

    Research output: Contribution to journalArticlepeer-review

    84 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'NeuroEndocrine tumor therapy with lutetium-177-octreotate and everolimus (NETTLE): A Phase I study'. Together they form a unique fingerprint.

    Medicine and Dentistry

    Pharmacology, Toxicology and Pharmaceutical Science